I have previously argued that we should use antitrust laws to break up the too big to fails.
Since I made that argument, economists Simon Johnson and Robert Reich have both said the same thing.
Specifically, former head IMF economist Simon Johnson wrote:
Increasingly, the issue of “too big to regulate” in the public interest is being brought up – an issue that has historically attracted the interest of the Department of Justice’s Antitrust Division in sectors other than finance. Should Goldman Sachs now be placed in this category?
And former Secretary of Labor Robert Reich wrote yesterday:
Neither the draft bill, nor the Committee, nor anyone on the Hill having anything to do with financial regulation, is raising what I consider to be the two key reforms necessary for avoiding another financial meltdown — resurrecting the Glass-Steagall Act that once separated commercial from investment banking, and applying antitrust laws to the remaining five biggest Wall Street banks so none is "too big to fail."
Stocks made a slight retreat on Thursday after two disappointing economic reports.
Although the Dow Jones Industrial Average managed to hit new record intraday and closing highs on Thursday, stocks generally declined in the wake of an awful report on initial unemployment claims from the Department of Labor. Initial claims for the week ending December 14 climbed by 10,000 to a dismal, 379,000. The four-week moving average climbed by 13,250 to 343,500. A Second Week of Higher Jobless Claims
The National Association of Realtors reported that ...
An automated banking utility has no need for parasitic bankers or politicos or indeed, a central bank.
Do we need a banking sector dominated by politically untouchable "Too Big to Fail" (TBTF) banks? Thanks to fast-advancing technology, the answer is a resounding no. Not only do we not need a banking sector, we would be immensely better off were the banking sector to wither and vanish from the face of the Earth, along with its parasitic class of political enablers, toadies and Federal Reserve apparatchiks.
USB – U.S. Bancorp – Shares in the financial services provider yesterday rallied to the highest level since September of 2008, moving sharply higher during the final two hours of the session on Wednesday following the Fed’s announcement that it will reduce its asset purchases by $10 billion starting in January. The stock is off 0.50% on Thursday to stand at $39.92 just before 11:30 a.m. in New York trading.
Trading in the regular Jan ’14 $39 strike puts on USB near the start of the session suggests at least one options player is bracing for the ...
Note from Doug: Having lived for two wonderful years in Paoli, PA, a suburb west of Philadelphia just south of Valley Forge, I have a special interest in this regional indicator. But, more importantly, it gives a generally reliable clue as to direction of the broader Chicago Fed's National Activity Index.
The Philly Fed's Business Outlook Survey is a monthly report for the Third Federal Reserve District, covers eastern Pennsylvania, southern New Jersey, and Delaware. The latest gauge of General Activity came in at 6.5, a statistically insignificant change from the previous month's 7.0. The 3-month moving average came in at 11.1, down from 16.2 last ...
Well, Fed Chairman Bernanke has proved me wrong by dipping his toe into the dreaded tapering of QE3. In retrospect, I suppose he preferred to take this first step on his own rather than put the onus (and any associated fallout) on the back on his successor. However, by wrapping his announcement with a pink bow and couching it in reassuring terms, stocks reacted favorably -- and on strong volume, to boot. In fact, I think it’s safe to say that Bernanke said all the right things and equity investors took it as the green flag for their widely-anticipated year-end rally. It’s always easier to forge ahead into uncharted territory when you know there’s someone powerful who’s got your back.
Despite an initially negative knee-jerk reaction to the Fed’s taper announcement, the Dow Industrials and ...
Board of Directors Violin Memory, Inc. 4555 Great American Parkway Santa Clara, CA 95054
I write on behalf of the Clinton Group, Inc., the investment manager to various funds and partnerships (“Clinton Group”) that own a meaningful stake in the common stock of Violin Memory, Inc. (“Violin Memory” or the “Company”).
I write both to thank the Board for its recent action in terminating Don Basile as Chief Executive Officer and to urge the Board to take the next logical step.
Mr. Basile deserved to be fired. In addition to the surprising and substantial financial and stock under-performance since the initial public offering, Mr. Basile was properly held accountable for significant strategic and operational missteps, including the failure to preserve the HP partnership, undisciplined growth i...
Reminder: OpTrader is available to chat with Members, comments are found below each post.
This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).
We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options.
Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.
To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here...
These rallies are becoming familiar. In early July we saw a streak of 12 of 13 sessions in a row up, early September 11 of 12, and mid October 11 of 13 (current streak). It is a bit uncanny the similarities and how the escalator goes straight up in vertical ascent as we see indexes come out of mini corrections during QE. So we are about at the same stage where the last two began to tire, so it will be interesting if this is similar or if the current consensus of the market that there is nothing to worry about until next year as the Fed and D.C. are both off the table and this 3% annual growth rate in earnings we are now seeing in the S...
Welcome to the fouth update of the IRA Virtual Portfolio. First I am going to summarize the current state of the Portfolio then I will get into all the activity we had during September expiration.
Profit and Loss – Net of closed positions the portfolio is up a total of $769
Market Commentary – Last expiration I said, "I would like to put a total of $20,000 to work by the end of SEP expiration. If the VIX pops up to around 20 I plan to put about $50,000 total to work." The market didn't quite reach the goal but I did manage to deploy $15,000 of buying power. I still feel the market is too high and expect a correction during October. If the vix pops up to around 20 I still plan to put about $50,000 to work. If a correction doesn't happen I still plan to have a total of $25,000 in buying power put to work by October expiration. Now on to the act...
Reminder: Pharmboy is available to chat with Members, comments are found below each post.
Come and get it! Read all about it! Biotechs, biotechs and more biotechs to buy buy buy for your portfolio! To date, almost 30 biotech companies have hit the market. Most of the time, there are fewer than 10-12!
For the last five years, biotechs have had issues obtaining offer prices above expectations. In 2013, that trend looks to be broken. According to BiotechNow, the offer prices are 4% above expectations! In addition, biotechs are going public with little more than a wing and a prayer (pre-clinical or Phase 1 data only). Really? What this means is that the drug or technology looks good in mice, rats, or dogs, etc, but there is no smidgen of evidence that it will work in humans. That's what is called an appitite for RISK!
Note: The material presented in this commentary is provided for informational purposes only and is based upon information that is considered to be reliable. However, neither Philstockworld, LLC (PSW) nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.